Functional α7β2 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid β peptides

BMC Neuroscience

Volumn 13, Issue 1, 2012, Pages

  Liu, Qiang ^a   Huang, Yao ^b   Shen, Jianxin ^c   Steffensen, Scott ^d   Wu, Jie ^a,c,e  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^d BRIGHAM YOUNG UNIVERSITY   (United States)

^e ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Acutely dissociated neuron; Amyloid; Hippocampal interneuron; Nicotinic acetylcholine receptor; Patch clamp

Indexed keywords

AMYLOID BETA PROTEIN; BUNGAROTOXIN RECEPTOR; NICOTINIC RECEPTOR BETA2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; HIPPOCAMPAL CA1 REGION; IMMUNOPRECIPITATION; INTERNEURON; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION;

AMYLOID BETA-PEPTIDES; ANIMALS; CA1 REGION, HIPPOCAMPAL; CELLS, CULTURED; DIHYDRO-BETA-ERYTHROIDINE; GABAERGIC NEURONS; GENE KNOCK-IN TECHNIQUES; INTERNEURONS; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, KNOCKOUT; NICOTINIC ANTAGONISTS; PEPTIDE FRAGMENTS; RECEPTORS, NICOTINIC;

EID: 84871543510     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-13-155     Document Type: Article

References (67)

1. Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999, 399(6738 Suppl):A23-31.
2. Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2006, 314(5800):777-781. 10.1126/science.1132814, 17082447.
3. Adams CE, Broide RS, Chen Y, Winzer-Serhan UH, Henderson TA, Leslie FM, Freedman R. Development of the alpha7 nicotinic cholinergic receptor in rat hippocampal formation. Brain Res Dev Brain Res 2002, 139(2):175-187. 10.1016/S0165-3806(02)00547-3, 12480132.
4. Buccafusco JJ, Letchworth SR, Bencherif M, Lippiello PM. Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance. Trends Pharmacol Sci 2005, 26(7):352-360. 10.1016/j.tips.2005.05.007, 15946748.
5. Jensen AA, Frolund B, Liljefors T, Krogsgaard-Larsen P. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem 2005, 48(15):4705-4745. 10.1021/jm040219e, 16033252.
6. Liu Q, Zhang J, Zhu H, Qin C, Chen Q, Zhao B. Dissecting the signaling pathway of nicotine-mediated neuroprotection in a mouse Alzheimer disease model. FASEB J 2007, 21(1):61-73.
7. Mudo G, Belluardo N, Fuxe K. Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms. J Neural Transm 2007, 114(1):135-147. 10.1007/s00702-006-0561-z, 16906354.
8. Kawai H, Zago W, Berg DK. Nicotinic alpha 7 receptor clusters on hippocampal GABAergic neurons: regulation by synaptic activity and neurotrophins. J Neurosci 2002, 22(18):7903-7912.
9. Liu Q, Kawai H, Berg DK. beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons. Proc Natl Acad Sci USA 2001, 98(8):4734-4739. 10.1073/pnas.081553598, 31903, 11274373.
10. Sudweeks SN, Yakel JL. Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. J Physiol 2000, 527(Pt 3):515-528. 2270092, 10990538.
11. Wang HY, Lee DH, D'Andrea MR, Peterson PA, Shank RP, Reitz AB. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem 2000, 275(8):5626-5632. 10.1074/jbc.275.8.5626, 10681545.
12. Wang HY, Lee DH, Davis CB, Shank RP. Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem 2000, 75(3):1155-1161.
13. Pettit DL, Shao Z, Yakel JL. beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. J Neurosci 2001, 21(1):RC120.
14. Grassi F, Palma E, Tonini R, Amici M, Ballivet M, Eusebi F. Amyloid beta(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors. J Physiol 2003, 547(Pt 1):147-157. 2342606, 12562926.
15. Lee DH, Wang HY. Differential physiologic responses of alpha7 nicotinic acetylcholine receptors to beta-amyloid1-40 and beta-amyloid1-42. J Neurobiol 2003, 55(1):25-30. 10.1002/neu.10203, 12605456.
16. Wu J, Kuo YP, George AA, Xu L, Hu J, Lukas RJ. beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells. J Biol Chem 2004, 279(36):37842-37851. 10.1074/jbc.M400335200, 15234980.
17. Liu Q, Huang Y, Xue F, Simard A, DeChon J, Li G, Zhang J, Lucero L, Wang M, Sierks M, et al. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides. J Neurosci 2009, 29(4):918-929. 10.1523/JNEUROSCI.3952-08.2009, 2857410, 19176801.
18. Dineley KT, Bell KA, Bui D, Sweatt JD. beta -Amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Biol Chem 2002, 277(28):25056-25061. 10.1074/jbc.M200066200, 11983690.
19. Fu W, Jhamandas JH. Beta-amyloid peptide activates non-alpha7 nicotinic acetylcholine receptors in rat basal forebrain neurons. J Neurophysiol 2003, 90(5):3130-3136. 10.1152/jn.00616.2003, 12890800.
20. Pym L, Kemp M, Raymond-Delpech V, Buckingham S, Boyd CA, Sattelle D. Subtype-specific actions of beta-amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4) expressed in Xenopus laevis oocytes. Br J Pharmacol 2005, 146(7):964-971. 10.1038/sj.bjp.0706403, 1751230, 16184187.
21. Larner AJ. Epileptic Seizures in AD Patients. Neuromolecular Med 2010, 12(1):71-7. 10.1007/s12017-009-8076-z, 19557550.
22. Minkeviciene R, Rheims S, Dobszay MB, Zilberter M, Hartikainen J, Fulop L, Penke B, Zilberter Y, Harkany T, Pitkanen A, et al. Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci 2009, 29(11):3453-3462. 10.1523/JNEUROSCI.5215-08.2009, 19295151.
23. Palop JJ, Mucke L. Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol 2009, 66(4):435-440. 2812914, 19204149.
24. Palop JJ, Mucke L. Synaptic Depression and Aberrant Excitatory Network Activity in Alzheimer's Disease: Two Faces of the Same Coin?. Neuromolecular Med 2009, 12(1):48-55. 3319077, 19838821.
25. Vogt DL, Thomas D, Galvan V, Bredesen DE, Lamb BT, Pimplikar SW. Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain. Neurobiol Aging 2011, 32(9):1725-1729. 10.1016/j.neurobiolaging.2009.09.002, 2889215, 19828212.
26. Wu MN, Li XY, Guo F, Qi JS. Involvement of nicotinic acetylcholine receptors in amyloid beta-fragment-induced intracellular Ca(2+) elevation in cultured rat cortical neurons. Sheng Li Xue Bao 2009, 61(6):517-525.
27. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007, 55(5):697-711. 10.1016/j.neuron.2007.07.025, 17785178.
28. Son JH, Winzer-Serhan UH. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs in rat hippocampal GABAergic interneurons. J Comp Neurol 2008, 511(2):286-299. 10.1002/cne.21828, 3271947, 18792073.
29. Buhler AV, Dunwiddie TV, Buhler AV, Dunwiddie TV. alpha7 nicotinic acetylcholine receptors on GABAergic interneurons evoke dendritic and somatic inhibition of hippocampal neurons. J Neurophysiol 2002, 87(1):548-557.
30. Wu J, George AA, Schroeder KM, Xu L, Marxer-Miller S, Lucero L, Lukas RJ. Electrophysiological, pharmacological, and molecular evidence for alpha7-nicotinic acetylcholine receptors in rat midbrain dopamine neurons. J Pharmacol Exp Ther 2004, 311(1):80-91. 10.1124/jpet.104.070417, 15178698.
31. Yang K, Hu J, Lucero L, Liu Q, Zheng C, Zhen X, Jin G, Lukas RJ, Wu J. Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons. J Physiol 2009, 587(Pt 2):345-361. 2670049, 19047205.
32. Chen D, Patrick JW. The alpha-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the alpha7 subunit. J Biol Chem 1997, 272(38):24024-24029. 10.1074/jbc.272.38.24024, 9295355.
33. Ji D, Lape R, Dani JA. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 2001, 31(1):131-141. 10.1016/S0896-6273(01)00332-4, 11498056.
34. Hefft S, Hulo S, Bertrand D, Muller D. Synaptic transmission at nicotinic acetylcholine receptors in rat hippocampal organotypic cultures and slices. J Physiol 1999, 515(Pt 3):769-776. 2269188, 10066903.
35. Dominguez Del Toro E, Juiz JM, Peng X, Lindstrom J, Criado M. Immunocytochemical localization of the alpha 7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system. J Comp Neurol 1994, 349(3):325-342. 10.1002/cne.903490302, 7852628.
36. Mielke JG, Mealing GA. Cellular distribution of the nicotinic acetylcholine receptor alpha7 subunit in rat hippocampus. Neurosci Res 2009, 65(3):296-306. 10.1016/j.neures.2009.08.003, 19682509.
37. Jones S, Yakel JL. Functional nicotinic ACh receptors on interneurones in the rat hippocampus. J Physiol 1997, 504(Pt 3):603-610. 1159964, 9401968.
38. Alkondon M, Pereira EF, Albuquerque EX. alpha-bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Res 1998, 810(1-2):257-263.
39. McQuiston AR, Madison DV. Nicotinic receptor activation excites distinct subtypes of interneurons in the rat hippocampus. J Neurosci 1999, 19(8):2887-2896.
40. Frazier CJ, Rollins YD, Breese CR, Leonard S, Freedman R, Dunwiddie TV. Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J Neurosci 1998, 18(4):1187-1195.
41. Lamb PW, Melton MA, Yakel JL. Inhibition of neuronal nicotinic acetylcholine receptor channels expressed in Xenopus oocytes by beta-amyloid1-42 peptide. J Mol Neurosci 2005, 27(1):13-21. 10.1385/JMN:27:1:013, 16055943.
42. Spencer JP, Weil A, Hill K, Hussain I, Richardson JC, Cusdin FS, Chen YH, Randall AD. Transgenic mice over-expressing human beta-amyloid have functional nicotinic alpha 7 receptors. Neuroscience 2006, 137(3):795-805. 10.1016/j.neuroscience.2005.10.007, 16303255.
43. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008, 14(8):837-842. 10.1038/nm1782, 2772133, 18568035.
44. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297(5580):353-356. 10.1126/science.1072994, 12130773.
45. Cirrito JR, Holtzman DM. Amyloid beta and Alzheimer disease therapeutics: the devil may be in the details. J Clin Invest 2003, 112(3):321-323. 166307, 12897198.
46. Burghaus L, Schutz U, Krempel U, De Vos RA, Jansen Steur EN, Wevers A, Lindstrom J, Schroder H. Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Brain Res Mol Brain Res 2000, 76(2):385-388. 10.1016/S0169-328X(00)00031-0, 10762715.
47. Nordberg A. Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol Psychiatry 2001, 49(3):200-210. 10.1016/S0006-3223(00)01125-2, 11230871.
48. Levin ED, Rezvani AH. Nicotinic treatment for cognitive dysfunction. Curr Drug Targets CNS Neurol Disord 2002, 1(4):423-431. 10.2174/1568007023339102, 12769614.
49. Geerts H. Indicators of neuroprotection with galantamine. Brain Res Bull 2005, 64(6):519-524. 10.1016/j.brainresbull.2004.11.002, 15639548.
50. Lahiri DK, Utsuki T, Chen D, Farlow MR, Shoaib M, Ingram DK, Greig NH. Nicotine reduces the secretion of Alzheimer's beta-amyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins. Ann N Y Acad Sci 2002, 965:364-372.
51. Nagele RG, D'Andrea MR, Anderson WJ, Wang HY. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 2002, 110(2):199-211. 10.1016/S0306-4522(01)00460-2, 11958863.
52. Sadot E, Gurwitz D, Barg J, Behar L, Ginzburg I, Fisher A. Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells. J Neurochem 1996, 66(2):877-880.
53. Freund TF, Buzsaki G. Interneurons of the hippocampus. Hippocampus 1996, 6(4):347-470.
54. Khiroug SS, Harkness PC, Lamb PW, Sudweeks SN, Khiroug L, Millar NS, Yakel JL. Rat nicotinic ACh receptor alpha7 and beta2 subunits co-assemble to form functional heteromeric nicotinic receptor channels. J Physiol 2002, 540(Pt 2):425-434. 2290261, 11956333.
55. Dineley KT, Xia X, Bui D, Sweatt JD, Zheng H. Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J Biol Chem 2002, 277(25):22768-22780. 10.1074/jbc.M200164200, 11912199.
56. Hellstrom-Lindahl E, Court J, Keverne J, Svedberg M, Lee M, Marutle A, Thomas A, Perry E, Bednar I, Nordberg A. Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice. Eur J Neurosci 2004, 19(10):2703-2710.
57. Hellstrom-Lindahl E, Mousavi M, Ravid R, Nordberg A. Reduced levels of Abeta 40 and Abeta 42 in brains of smoking controls and Alzheimer's patients. Neurobiol Dis 2004, 15(2):351-360. 10.1016/j.nbd.2003.11.024, 15006705.
58. Hellstrom-Lindahl E, Mousavi M, Zhang X, Ravid R, Nordberg A. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Brain Res Mol Brain Res 1999, 66(1-2):94-103.
59. Jones IW, Westmacott A, Chan E, Jones RW, Dineley K, O'Neill MJ, Wonnacott S. Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes. J Mol Neurosci 2006, 30(1-2):83-84.
60. Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, Staufenbiel M, Konnerth A, Garaschuk O. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 2008, 321(5896):1686-1689. 10.1126/science.1162844, 18802001.
61. Alkondon M, Albuquerque EX. Nicotinic acetylcholine receptor alpha7 and alpha4beta2 subtypes differentially control GABAergic input to CA1 neurons in rat hippocampus. J Neurophysiol 2001, 86(6):3043-3055.
62. Ji D, Dani JA. Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons. J Neurophysiol 2000, 83(5):2682-2690.
63. Potier B, Jouvenceau A, Epelbaum J, Dutar P. Age-related alterations of GABAergic input to CA1 pyramidal neurons and its control by nicotinic acetylcholine receptors in rat hippocampus. Neuroscience 2006, 142(1):187-201. 10.1016/j.neuroscience.2006.06.040, 16890374.
64. Yan Z, Feng J. Alzheimer's disease: interactions between cholinergic functions and beta-amyloid. Curr Alzheimer Res 2004, 1(4):241-248. 10.2174/1567205043331992, 15975053.
65. Tamamaki N, Yanagawa Y, Tomioka R, Miyazaki J, Obata K, Kaneko T. Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J Comp Neurol 2003, 467(1):60-79. 10.1002/cne.10905, 14574680.
66. Brown RE, McKenna JT, Winston S, Basheer R, Yanagawa Y, Thakkar MM, McCarley RW. Characterization of GABAergic neurons in rapid-eye-movement sleep controlling regions of the brainstem reticular formation in GAD67-green fluorescent protein knock-in mice. Eur J Neurosci 2008, 27(2):352-363. 10.1111/j.1460-9568.2008.06024.x, 2376819, 18215233.
67. Wu J, Chan P, Schroeder KM, Ellsworth K, Partridge LD. 1-Methyl-4-phenylpridinium (MPP+)-induced functional run-down of GABA(A) receptor-mediated currents in acutely dissociated dopaminergic neurons. J Neurochem 2002, 83(1):87-99. 10.1046/j.1471-4159.2002.01099.x, 12358732.